Enlightening disease

Exploring the potential of advanced therapies through allogeneic cells

Our pipeline is focused on unlocking the potential of advanced cellular therapies through allogeneic cells, by exploring investigational approaches for clinical areas with limited therapeutic options. We focus on the use of mesenchymal stem cells for regenerative tissue in dermatology. In addition, we are involved in external programs focused on inmune restoration using allogeneic cells, offering a scalable manufacturing infraestructure compliant with current European regulatory standards.

Project Pipeline

Project

Area

Pathology

Type of Cell

Cellular Source

IP

Preclinical

Phase I

Phase IIa and Phase IIb

Phase III

MA

Dermatology

AGA

Mesenchymal stem cells

Allogenic

WO/2025/133317

Immunology

Heart Transplant Children

Thymic cells

Autologous

WO/2019/16665

 

EP3759215

AGAcell®:

The first pre-clinical research program exploring an allogeneic therapy with mesenchymal stem cells for androgenetic alopecia